BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,070.00
-75.00 (-2.38%)
At close: Mar 28, 2025, 3:30 PM KST
-46.98%
Market Cap 25.11B
Revenue (ttm) 12.35B
Net Income (ttm) -5.40B
Shares Out 8.18M
EPS (ttm) -660.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,149
Average Volume 5,781
Open 3,125.00
Previous Close 3,145.00
Day's Range 3,050.00 - 3,155.00
52-Week Range 2,750.00 - 5,890.00
Beta 1.11
RSI 45.55
Earnings Date Mar 17, 2025

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 99
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.